The Ulthera System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy – the procedure enabled by the System – is a non-invasive treatment of the face to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital.
Employees: 201-500
Phone: +1 844-469-6379
Total raised: $10.5M
Founded date: 2004
Investors 2
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | Questa Cap... | questacapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.02.2011 | Series C | $10.5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 08.02.2011 | Ulthera Raises $10.5M in Series C Venture Funding | Ulthera, Inc., a Mesa, Ariz.-based developer of a ultrasound device approved by the FDA for aesthetics, raised $10.5m in Series C venture funding. The round was led by New Enterprise Associates (NEA), with participation from funds managed b... |
| 18.01.2008 | Life sciences briefing: Friday, Jan. 18, 2007 | TODAY’S HEADLINES: Ulthera receives $23M for cosmetic ultrasound devices (release) Senexis raises £2.9M for Alzheimer’s drugs (PDF release) Elixir Pharma postpones IPO (IPO Home) Cancer Therapeutics names Randall Riggs as CEO (release) Ulth... |